Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

Pfizer's stock experienced a 2.66% increase on June 9, 2025, closing at $23.97, marking its second consecutive day of gains.

Shares of Pfizer Inc. PFE rallied 2.66% to $23.97 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.09% to 6,005.88 and the Dow ...

BMY is looking to expand its pipeline/portfolio as the legacy portfolio is being adversely impacted due to continued generic ...

Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, ...

A volatile stock market represents an ideal opportunity for long-term investors to pounce.

Key Drivers of Pfizer’s Stock Performance 1. Moving on From COVID ... Pfizer Stock Price Target for 2030 Based on our analysis, 24/7 Wall St. projects shares of Pfizer to be trading for $34.08 by the ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. The group holding the most ...

the stock appears undervalued based on its Fair Value estimates, suggesting potential upside for investors. This comprehensive analysis examines Pfizer’s current position, recent performance, and ...

the stock appears undervalued based on its Fair Value estimates, suggesting potential upside for investors. This comprehensive analysis examines Pfizer’s current position, recent performance ...